New Antidepressant ALKS 5461 Trials: 2016 Expected Availability
ALKS-5461 is a new drug that is being developed by the company Alkermes as an alternative to SSRI’s for the treatment of depression. ALKS-5461 (its trial name) is a combination of both bupre…
Read article